mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.009 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.01 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |